23 Jun 2025
// GLOBENEWSWIRE
21 Jun 2025
// PRESS RELEASE
17 Jun 2025
// PRESS RELEASE
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Exhibiting
08-10 September, 2025
Contract PharmaContract Pharma
Industry Trade Show
Exhibiting
18-19 September, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Exhibiting
08-10 September, 2025
Contract PharmaContract Pharma
Industry Trade Show
Exhibiting
18-19 September, 2025
https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103111/0/en/141-959-Orion-Corporation-A-shares-converted-into-B-shares.html
21 Jun 2025
// PRESS RELEASE
https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2025/chmp-recommends-third-indication-for-darolutamide-for-patients-with-advanced-prostate-cancer/
17 Jun 2025
// PRESS RELEASE
https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2025/orion-and-glykos-announce-the-extension-of-their-research-collaboration-and-licensing-agreement-for-the-development-of-next-generation-adcs/
03 Jun 2025
// PRESS RELEASE
https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2025/u.s.-fda-approves-third-indication-of-darolutamide-for-patients-with-advanced-prostate-cancer
23 May 2025
// PRESS RELEASE
https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2025/orion-announces-agreement-with-shilpa-medicare-for-recombinant-human-albumin-for-european-market/
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3086316/0/en/Orion-to-host-Capital-Markets-Day-today-22-May-2025-in-Helsinki.html
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 50
Dosage Strength : 12.5MG;200MG;50MG
Approval Date : 2003-06-11
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 100
Dosage Strength : 25MG;200MG;100MG
Approval Date : 2003-06-11
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 150
Dosage Strength : 37.5MG;200MG;150MG
Approval Date : 2003-06-11
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 200
Dosage Strength : 50MG;200MG;200MG
Approval Date : 2007-08-02
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 75
Dosage Strength : 18.75MG;200MG;75MG
Approval Date : 2008-08-29
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
CARBIDOPA; ENTACAPONE; LEVODOPA
Dosage Form : TABLET; ORAL
Proprietary Name : STALEVO 125
Dosage Strength : 31.25MG;200MG;125MG
Approval Date : 2008-08-29
Application Number : 21485
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : COMTAN
Dosage Strength : 200MG
Approval Date : 1999-10-19
Application Number : 20796
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
Inspections and registrations
ABOUT THIS PAGE
Orion Corporation is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Pyrantel Pamoate bulk offered by Orion Corporation
Find a price of MANUFACTURING OPERATIONS bulk offered by Orion Corporation